Tramontane Therapeutics
A gene therapy company aimed at successfully developing treatments for highly prevalent metabolic and neurodegenerative diseases affecting large population of patients.
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Acquisition | |
Total Funding | - |